首页> 外文期刊>Research Journal of Pharmaceutical Sciences >Hepatoprotective Activity of Kadukkai Maathirai (A Siddha Polyherbal Formulation) Against Carbon Tetrachloride Induced Liver Damage in Rat
【24h】

Hepatoprotective Activity of Kadukkai Maathirai (A Siddha Polyherbal Formulation) Against Carbon Tetrachloride Induced Liver Damage in Rat

机译:Kadukkai Maathirai(悉达多草药配方)对四氯化碳诱导的大鼠肝损伤的肝保护活性

获取原文
       

摘要

Kadukkai maathirai (KM) is a polyherbal formulation used in traditional Siddha Medicine for the treatment of liver diseases and iron deficiency anemia. This study was aimed to create preclinical scientific evidence on hepatoprotective activity of KM. Five groups, with six rats in each group were used in this study. Group 1 (normal rats) did not receive any drug. Group 2, 3, 4 and 5 received carbon tetrachloride (CCl_(4)) 1mg/kg twice a week (on third day and seventh days of each week) for four weeks to induce hepatic damage. Group 2 (vehicle control) received only vehicle. Group 3 and group 4 were treated with two doses of KM, 36mg/kg and 72mg/kg respectively for 28 days. Group 5 (standard) received silymarin 25mg/Kg for 28 days. On 29~(th) day, blood was collected for estimation of aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP)and total bilirubin (TB). Liver was collected for histopathological examination. Group 2 showed significant (P < 0.001) increase in levels of AST, ALT, ALP and TB compared to group 1 indicating the liver damage caused by CCl_(4). KM treated Group 3 and group 4 showed a dose dependent reduction of all enzyme levels. Group 3 and group 4 showed significant (P < 0.001) reduction in AST, ALT, ALP and TB levels when compared to vehicle control indicate the recovery of hepatic cells. Histology examination revealed that KM treatment reduced the hepatocellular necrosis in a dose dependent manner. Our study demonstrated the dose dependent hepatoprotective activity of KM against CCl_(4) induced liver injury. However, future study will be directed on molecular mechanism of individual ingredients, toxicity profile and clinical studies in various liver diseases.
机译:Kadukkai maathirai(KM)是一种用于传统悉达医学(Siddha Medicine)中的多草药制剂,用于治疗肝脏疾病和铁缺乏性贫血。这项研究旨在为KM的肝保护活性提供临床前科学证据。本研究使用了五组,每组六只大鼠。第一组(正常大鼠)未接受任何药物。第2、3、4和5组每周两次(每周的第三天和第七天)接受两次四氯化碳(CCl_(4))1mg / kg的治疗,持续四周,以引起肝损伤。第2组(车辆控制)仅接收车辆。第3组和第4组分别用两种剂量的KM(36mg / kg和72mg / kg)治疗28天。第5组(标准组)接受水飞蓟素25mg / Kg给药28天。在第29天,收集血液以评估天冬氨酸转氨酶(AST),丙氨酸转氨酶(ALT),碱性磷酸酶(ALP)和总胆红素(TB)。收集肝脏用于组织病理学检查。与第1组相比,第2组显示AST,ALT,ALP和TB的水平显着提高(P <0.001),表明由CCl_(4)引起的肝损害。 KM处理的第3组和第4组显示出所有酶水平的剂量依赖性降低。与媒介物对照相比,第3组和第4组显示AST,ALT,ALP和TB水平显着降低(P <0.001),表明肝细胞已恢复。组织学检查显示KM治疗以剂量依赖性方式减少了肝细胞坏死。我们的研究表明KM对CCl_(4)诱导的肝损伤的剂量依赖性肝保护活性。但是,未来的研究将针对各种肝脏疾病中各个成分的分子机理,毒性概况和临床研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号